Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan · Delayed Price · Currency is TWD 183.50
+3.50 (1.94%)
Aug 12, 2025, 1:30 PM CST
Alar Pharmaceuticals Company Description
Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.
The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia.
Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.
Alar Pharmaceuticals Inc.
| Country | Taiwan |
| Founded | 2016 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 27 |
| CEO | Yung-Shun Wen |
Contact Details
Address: No. 32, Keya Road Taichung Taiwan | |
| Phone | 886 4 2463 7115 |
| Website | alarpharm.com |
Stock Details
| Ticker Symbol | 6785 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006785009 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Yung-Shun Wen Ph.D. | Chief Executive Officer and Director |
| Vivian Kang | Accounting Supervisor and Director of Finance |